Welcome to our dedicated page for Advanced Flower Capital SEC filings (Ticker: AFCG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Advanced Flower Capital Inc. filings document the regulatory record of a Nasdaq-listed business development company that makes direct senior debt investments for lower middle-market borrowers. Its 8-K reports furnish operating results, financial presentations, net investment income, NAV, Distributable Earnings, distributions, investment fundings, and leverage disclosures.
The company’s filings also cover material definitive agreements and direct financial obligations, including revolving credit agreements and amendments to its loan and security agreement. Proxy and shareholder-vote materials document governance matters, director elections, auditor ratification, the investment advisory agreement with AFC Management, LLC, reduced asset coverage matters under the Investment Company Act of 1940, and capital-structure information for AFCG common stock.
Advanced Flower Capital Inc. (AFCG) reported an insider equity award for its Chief Executive Officer. On 11/20/2025, the CEO acquired 91,240 shares of common stock as restricted stock granted under the company’s Stock Incentive Plan, fully vested as of that date, at a price of $2.74 per share. Following this grant, the CEO beneficially owns 317,889 shares of AFCG common stock in direct ownership. This filing is a disclosure of executive equity compensation and does not reflect an open-market purchase or sale.
Advanced Flower Capital Inc. (AFCG) reported an insider equity award for its President and CIO on a Form 4. On November 20, 2025, the executive acquired 91,240 shares of common stock as fully vested restricted stock granted under the company’s stock incentive plan at a price of $2.74 per share.
Following this transaction, the executive directly held 218,907 shares of AFCG common stock. Additional shares are reported as indirectly owned through the executive’s spouse and the Tannenbaum Family Foundation, but the executive disclaims beneficial ownership of those securities except to the extent of any pecuniary interest.
Advanced Flower Capital Inc. (AFCG) director and 10% owner reported acquiring 729,927 shares of common stock on November 20, 2025 as a fully vested restricted stock grant under the company’s stock incentive plan, at a reported price of $2.74 per share. Following this transaction, the reporting person directly owns 5,692,098 shares of AFCG common stock.
In addition to these directly held shares, the filing shows indirect holdings of 218,907 shares held by the reporting person’s spouse and 180,400 shares held by the Tannenbaum Family Foundation, where the reporting person serves as President. The reporting person disclaims beneficial ownership of the spouse and foundation shares except to the extent of any pecuniary interest.
Advanced Flower Capital Inc. (AFCG) Chief Executive Officer reported an open‑market purchase of company stock. On 11/18/2025, the reporting person bought 17,000 shares of common stock in a single reportable transaction coded "P" for purchase. The weighted average price was $2.81 per share, with individual trades executed between $2.79 and $2.81.
Following this transaction, the reporting person beneficially owned 226,649 shares of AFCG common stock, held directly. The filer has undertaken to provide full trade details, including the number of shares and exact prices for each execution, to the SEC staff, the issuer, or any security holder upon request.
Advanced Flower Capital Inc. furnished an update on operations and financial condition by announcing it issued a press release for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1. The information under Item 2.02, including the exhibit, is being furnished and is not deemed filed or incorporated by reference except as expressly set forth.
Advanced Flower Capital Inc. (AFCG) reported Q3 2025 results marked by higher credit costs and a swing to losses. Interest income was $8.16 million for the quarter, with a net loss of $12.49 million (vs. income a year ago). Year‑to‑date, the company recorded a net loss of $21.59 million.
The CECL reserve rose to $51.17 million as of September 30, 2025 (from $30.42 million at December 31, 2024), reflecting credit deterioration, including three nonaccrual loans with amortized cost of about $104.2 million. A loan held at fair value tied to Private Company A remained on nonaccrual with $50.98 million outstanding principal and $16.92 million fair value, driving $11.45 million of unrealized losses year‑to‑date.
Liquidity declined as cash was $45.12 million (vs. $103.61 million at year‑end). Debt included $22.0 million outstanding on the revolver and $89.06 million net in 2027 senior notes. The revolver maturity was extended to April 29, 2028 with an increased rate floor. AFCG expanded its investment mandate beyond cannabis to ancillary and other industries, and on November 6, 2025 shareholders approved a new investment advisory agreement necessary for the planned REIT‑to‑BDC conversion.
Advanced Flower Capital Inc. (AFCG) reported shareholder approvals tied to its planned conversion from a REIT to a business development company (BDC). Shareholders approved a new 1940 Act–compliant investment advisory agreement with AFC Management, LLC, and authorized applying the BDC reduced asset coverage standard.
The investment advisory agreement was approved with 13,174,530 votes for, 541,875 against, and 124,887 abstentions. The reduced asset coverage requirement—permitting leverage at a 150% asset coverage ratio instead of 200%—was approved with 12,903,849 votes for, 790,942 against, and 146,501 abstentions. As of the September 15, 2025 record date, 22,594,541 common shares were outstanding and entitled to vote.
Advanced Flower Capital Inc. proposes to convert from a REIT to a BDC regulated under the Investment Company Act, subject to shareholder approval at a virtual Special Meeting on November 6, 2025. The Board unanimously approved the Conversion and recommends voting in favor of two primary proposals required to effect the Conversion: (1) approval of a new 1940 Act-compliant investment advisory agreement with AFC Management, LLC and (2) approval of reduced asset coverage from 200% to 150%, which would permit materially greater leverage.
The Company would cease REIT treatment and operate as an externally managed, closed-end, non-diversified BDC, and intends to elect RIC tax treatment under Subchapter M after conversion, expected as early as the first quarter of 2026. The Proxy discloses benefits the Board expects—broader investment mandate, access to private and middle-market opportunities, and potential for approximately $201 million of additional borrowing capacity under the 150% asset coverage scenario—but also details risks including different regulatory limits on leverage, increased compliance and reporting obligations, changed fee and incentive structures, and an active legal complaint filed September 9, 2025 naming the Company and affiliates.
Leonard M. Tannenbaum, a director and listed 10% owner of Advanced Flower Capital Inc. (AFCG), purchased 79,665 shares on 09/05/2025 at a weighted average price of $4.56 per share (trades ranged $4.51–$4.61). After the transaction his direct beneficial ownership is reported as 4,962,171 shares. The filing also discloses 127,667 shares held by his spouse (disclaimed) and 180,400 shares held by the Tannenbaum Family Foundation, for which he serves as President (disclaimed except for pecuniary interest). The report was signed by an attorney-in-fact on 09/08/2025. No derivative transactions or additional material terms are reported in this Form 4.
Advanced Flower Capital Inc. (AFCG) reported an insider purchase by Chief Executive Officer and Director Daniel Neville. On 09/08/2025 Mr. Neville acquired 12,388 shares of the issuer's common stock at a weighted average price of $4.44 per share, bringing his total beneficial ownership to 209,649 shares. The Form 4 indicates the transaction code P and notes the trade executed in multiple fills priced between $4.40 and $4.45, with the filer offering to provide detailed trade-level information upon request. The filing was submitted by Gabriel A. Katz as attorney-in-fact and lists Neville's business address in West Palm Beach, FL.